| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 77.79B | 65.13B | 53.59B | 42.89B | 53.45B | 46.80B |
| Gross Profit | 25.33B | 21.24B | 19.41B | 17.00B | 16.64B | 14.14B |
| EBITDA | 20.88B | 16.91B | 16.95B | 16.31B | 9.85B | 12.28B |
| Net Income | 7.57B | 7.49B | 5.44B | 6.19B | 3.00B | 6.19B |
Balance Sheet | ||||||
| Total Assets | 318.47B | 218.47B | 218.97B | 180.32B | 179.61B | 168.86B |
| Cash, Cash Equivalents and Short-Term Investments | 2.54B | 1.18B | 1.80B | 5.90B | 861.00M | 286.00M |
| Total Debt | 152.85B | 106.50B | 101.67B | 81.20B | 80.98B | 75.64B |
| Total Liabilities | 222.89B | 152.55B | 150.08B | 115.83B | 116.21B | 105.50B |
| Stockholders Equity | 90.67B | 62.33B | 65.90B | 61.45B | 59.89B | 60.83B |
Cash Flow | ||||||
| Free Cash Flow | 2.16B | 3.98B | 5.67B | 9.32B | 6.41B | 1.97B |
| Operating Cash Flow | 12.17B | 12.95B | 12.60B | 14.20B | 11.23B | 9.79B |
| Investing Cash Flow | -12.60B | -11.17B | -20.36B | -6.04B | -5.27B | -11.18B |
| Financing Cash Flow | 291.11M | -2.41B | 3.54B | -2.86B | -5.43B | 1.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | C$39.38B | 18.16 | 9.98% | 5.44% | -5.92% | -12.92% | |
71 Outperform | C$100.34B | 24.46 | 12.53% | 4.41% | 1.37% | -24.17% | |
69 Neutral | C$171.59B | 16.87 | 11.41% | 5.80% | 13.47% | 9.15% | |
69 Neutral | C$16.51B | 25.03 | 5.92% | 2.99% | 1.11% | -13.38% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
64 Neutral | C$13.38B | -25.29 | 6.59% | 4.81% | -11.59% | -67.03% | |
54 Neutral | C$4.98B | -916.52 | 16.60% | 6.61% | -4.83% | -9.94% |